RT @SABOURETCardio
Efficacy and Safety of #Alirocumab 300 mg Every 4 Weeks in Individuals With #T2D. Efficient and well tolerated 1/month. Associated with fixed #LLT combinations HI #statins and #ezetimibe #lipids https://academic.oup.com/jcem/article-abstract/104/11/5253/5510497
#alirocumab #T2D #llt #statins #ezetimibe #lipids